TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Norfolk Quality of Life - Diabetic Neuropathy
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Achievement of the target office blood pressure (< 140/90 mmHg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Achievement of the target systolic office blood pressure (< 140 mmHg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Achievement of the target diastolic office blood pressure (< 90 mmHg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Full spine PA radiography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fMRI signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: PET signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: H-MRS Glutamate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Lithium levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Quality of Life From Mucositis-related Pain
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Sensitivity and specificity of HRUS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median Overall survival (OS)
Endpoint domain: Mortality/survival
Primary endpoint: Rate of Adverse Drug Reaction (ADR)
Endpoint domain: Adverse events/effects
Primary endpoint: Coronary artery flow using thrombolysis in myocardial infarction (TIMI) flow grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Coronary TIMI frame count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Slow flow / no-reflow phenomenon
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Ongoing pregnancy rate per cycle
Endpoint domain: Mortality/survival
Primary endpoint: Time to pregnancy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mean change in HbA1c levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Annualized rate of adverse events (local and systemic)
Endpoint domain: Adverse events/effects
Primary endpoint: Physician global assessment of severity (PGAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Conversion rate to open
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Fractional catabolic rate of apoB, apoA, apoC-III and chylomicron remnants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Production rate of apoB, apoA, apoC-III and chylomicron remnants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Recurrent Symptomatic Venous Thromboembolism (VTE)
Endpoint domain: Mortality/survival
Primary endpoint: Deaths Related to VTE
Endpoint domain: Mortality/survival
Primary endpoint: Modified Schober's test (MST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Skin Prick Tests evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Nasal airway temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Time to Therapy Augmentation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Therapy Switching
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Therapy Discontinuation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Therapy Duration
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Numbers of Therapy-days Dispensed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Daily Dosage
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence of vaso-occlusive events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aortic inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart Health Risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: systolic finger blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Numeric Rating Scale (NRS-11)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body Weight (kg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetics of metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rest Heart Rate Variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes from baseline in clinical laboratory parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum Urate Level < 5.0 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Presence of biochemical bone turnover
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Patient satisfaction using the PGI-I score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in 24-hour pad weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visibility of the stromal demarcation line
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Differing Severity of Adjacent Level Ossification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frenchay Activities Index (FAI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Functional Assessment of Cancer Therapy scale (FACT)-fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Diagnostic accuracy of FXIII-AP and D-dimer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quality of labor epidural analgesia/anesthesia
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Complete Change From Conventional Cigarettes - Self Report
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Complete Change From Conventional Cigarettes - Biochemically Verified
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seizure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pain Outcomes Questionnaire (POQ)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Changes in Caregiver Burden Score
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Change in patient comfort and satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: PROMIS Pain Intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of urination frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in Latency During the Learning Phase of Virtual Morris Water Maze Test (vMWM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Birth
Endpoint domain: Mortality/survival
Primary endpoint: CMV-specific immunity kinetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CMV replication kinetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Replication of EBV, HHV-6, and HHV-7
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Percentage of Participants Who Achieved Success in Investigator's Static Global Assessment (ISGA) Score at Day 29
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of Participants With Clinically Significant Change From Baseline in Electrocardiogram (ECG) Findings at Day 8
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Occurrence of cervical high-grade squamous intraepithelial lesions (HSIL) or cervical cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Difference in glucagon secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Complete Healing of Ulcer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Homeostatic Model Assessment ratio (HOMA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Health Education Impact Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Patients With Major Complications, Within 30 Days of Procedure
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants Achieving >= 4 Points Improvement in PP-NRS4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Percentage of Participants Achieving >= 90% Improvement in EASI-90
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: differential vascularity assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change from baseline in severity of GAD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in severity of worry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum effect (Emax) for Drug Liking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Elimination of Dermatophytomas
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Bronchial hyperreactivity measured as exhaled NO
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Post-Concussion Symptom Scale (PCSS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pediatric Risk of Mortality score on admission
Endpoint domain: Mortality/survival
Primary endpoint: Rate of Primary Ischemic Endpoint events (CCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of Primary Ischemic Endpoint events (NSTE-ACS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of Primary Bleeding Endpoint event (CCS)
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of Primary Bleeding Endpoint event (NSTE-ACS)
Endpoint domain: Adverse events/effects
Primary endpoint: Acute Infection
Endpoint domain: Adverse events/effects
Primary endpoint: Change in SpO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Narcotic Consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Emotion Recognition Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree and number of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Grade 1 and Higher Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Presence or absence of abnormality in 15q11q13 gene
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of inquirers who enroll in obesity treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: noradrenaline free time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mtDNA damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in smoking abstinence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Lateral cephalometry X-ray results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: velocity of the hepatic circulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: diameter of the vessels of the hepatic circulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood flow of the hepatic circulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health Related Quality Of Life (HRQOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Level of Engagement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Service Engagement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in LDL-c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Conflict Tactics Scale-Structured Interview (CTS-SI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of Patients With Local Control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AF burden 6-month after ablation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events of the ablation procedure
Endpoint domain: Adverse events/effects
Primary endpoint: Adherence to life-modifying treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achievement of the target LDL-C and BP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Tumor Volume Measure Using Grayscale US
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: VCEUS Perfusion Time to Peak
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sustained Platelet Transfusion Responsiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Infant weight gain trajectory
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in sleep development during hospitalization
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in sleep development after discharge home
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Multi-site Pain Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom From the Composite of Any Death, Stroke and MI
Endpoint domain: Mortality/survival
Primary endpoint: improvement of β-cell function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: remission rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of PHNO, PET ligand, occupancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time course of GSK618334 concentration in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of bailout
Endpoint domain: Adverse events/effects
Primary endpoint: Change over time of OSDI score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change over time of Visual analogue scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change over time of Tear osmolarity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change over time of Tear film breakup time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change over time of Corneal staining
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: remission without corticosteroids and without surgical resection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of Restless Legs Syndrome (RLS) at Bedtime
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of Restless Legs Syndrome (RLS) During the Night
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Any new stroke events
Endpoint domain: Mortality/survival
Primary endpoint: Diet Adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Confirmed Hernia Recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With TEAEs Leading to Permanent Discontinuation of Study Intervention
Endpoint domain: Adverse events/effects
Primary endpoint: Change in the rate of missed vaccination opportunities
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Laryngeal view as index of ease of insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Respiratory index values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Static Balance Assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional Balance Assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Self-reported Outcomes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Release of gut hormones
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Rate of successful catheterizations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Procedure success rate depending on physician experience
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Migration ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proliferation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spirometry measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Salivary fluoride concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: treatment incidence density
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Overall Survival (OS) at Month 6 Post HCT
Endpoint domain: Mortality/survival
Primary endpoint: Overall Survival (OS) at Year 2 Post HCT
Endpoint domain: Mortality/survival
Primary endpoint: Overall Survival (OS) at Year 5 Post HCT
Endpoint domain: Mortality/survival
Primary endpoint: Overall Survival (OS) at Year 8 Post HCT
Endpoint domain: Mortality/survival
Primary endpoint: Visual Analogue Scale of pain at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analogue Scale of pain at cough
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in QTc Interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence Rate of the Composite Efficacy Outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence Rate of a Major Bleeding Event
Endpoint domain: Adverse events/effects
Primary endpoint: Pharmacokinetics of paliperidone formulations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Disease Activity Score 28 Erythrocyte Sedimentation Rate (DAS28 [ESR])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Days of complication-free use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Morbidity (infection, malposition, bleeding, thrombosis, need for removal for catheter-related complication)
Endpoint domain: Adverse events/effects
Primary endpoint: Need for additional catheter placement or reintervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change from Baseline in urine albumin/creatinine ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: CoV-2 Infection after 21 days
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of RECELL-treated Area Closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Incidence of RECELL Donor Site Healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in weight-bearing physical activity (steps/day)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vitamin B12 status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage Change of Alanine Aminotransferase From Baseline at Week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Platelet count response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: feasibility of isometric exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tracer enrichment in the muscle biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Score of Acute toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Score of Late toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Caregiver's perceived social support
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Chronic pain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Bacilli Negative Conversion Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Mean Change in Capillary Non-Perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes